Net revenue of CHF 286.7 million (2023: CHF 297.3 million), reflecting a decline of 1.6% at constant currencies and of 3.6% at actual currencies EBITDA of CHF 21.3 million (2023: CHF 30.1 million) ...

Ascom Holding AG (VTX:ASCN) shareholders are probably feeling a little disappointed, since its shares fell 2.5% to CHF3.75 in the week after its latest annual results. It looks like the results were a ...

Ascom, a global leader in mission-critical communication and collaboration solutions across the healthcare and enterprise industries, announces that the Ascom Myco 4 has achieved a significant ...

Digitalization in the industrial sector, known as Industry 4.0, is transforming how the sector operates. The Ascom Enterprise Platform is helping its industrial customers reap the productivity ...

The Ascom Myco is designed around the needs of the nurse, from its size, weight and toughness to the presentation of information and the management of clinical workflows. GOTHENBURG, Sweden--(BUSINESS ...

Guidance for the fiscal year 2025: Ascom reconfirms its full-year guidance with low single-digit revenue growth at constant currencies and an EBITDA margin of 9–10%. Ascom strategy 2025: mid-year ...

Ascom announced that EHR provider MEDITECH has certified the Ascom Myco 3 smartphone with its Expanse Point of Care solution. Nurses, therapists, aides, and other clinicians can now complete most ...

The average one-year price target for Ascom Holding (SIX:ASCN) has been revised to 16.06 / share. This is an increase of 9.12% from the prior estimate of 14.72 dated August 31, 2023. The price target ...

In a challenging market environment, Ascom generated net revenue of CHF 286.7 million for fiscal year 2024 (2023: CHF 297.3 million), which reflects a decline of 1.6% at constant currencies and of 3.6 ...